Fetroja

— THERAPEUTIC CATEGORIES —
  • Bacterial infections

Fetroja Generic Name & Formulations

General Description

Cefiderocol 1gm; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; contains sodium 176mg/vial.

Pharmacological Class

Cephalosporin.

How Supplied

Single-dose vials—10

Manufacturer

Generic Availability

NO

Fetroja Indications

Indications

Susceptible complicated urinary tract infections (cUTI), including pyelonephritis. Susceptible hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP).

Fetroja Dosage and Administration

Adult

Give by IV infusion over 3hrs. Treat for 7–14 days. ≥18yrs (CrCl 60–119mL/min): 2g every 8hrs. (CrCl 30–59mL/min): 1.5g every 8hrs. (CrCl 15–29mL/min): 1g every 8hrs. ESRD (CrCl <15mL/min) with or without hemodialysis: 0.75g every 12hrs. (CrCl ≥120mL/min): 2g every 6hrs. On hemodialysis: initiate immediately after session. CCRT: see full labeling.

Children

<18yrs: not established.

Fetroja Contraindications

Not Applicable

Fetroja Boxed Warnings

Not Applicable

Fetroja Warnings/Precautions

Warnings/Precautions

Increase in all-cause mortality (see full labeling); monitor. Reserve for use in those who have limited or no alternative treatment options. Penicillin or other beta-lactam allergy. Discontinue if an allergic reaction occurs. Seizure disorder. Other CNS reactions (eg, nonconvulsive status epilepticus, encephalopathy, coma). Renal impairment: monitor. Elderly: monitor renal function. Pregnancy. Nursing mothers.

Fetroja Pharmacokinetics

See Literature

Fetroja Interactions

Interactions

May cause false (+) results in dipstick tests (urine protein, ketones, occult blood); use alternative methods to confirm (+) tests.

Fetroja Adverse Reactions

Adverse Reactions

Diarrhea, infusion site reactions, constipation, rash, candidiasis, cough, elevations in liver tests, headache, hypokalemia, nausea, vomiting, hypomagnesemia, atrial fibrillation; C. difficile-associated diarrhea, hypersensitivity reactions.

Fetroja Clinical Trials

See Literature

Fetroja Note

Not Applicable

Fetroja Patient Counseling

See Literature